Model based process design for a monoclonal antibody-producing cell line : optimisation using hybrid modelling and an agent based system
The biopharmaceutical industry has seen rapid growth over the last 10 years in the area of therapeutic medicines. These include products such as monoclonal antibodies (mAbs) produced using mammalian cell lines such as Chinese Hamster Ovary (CHO). In order to comply with the regulatory authority (FDA...
| Main Author: | |
|---|---|
| Published: |
University of Newcastle upon Tyne
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.692658 |